HR9547Referred to Committee

To direct the Secretary of Defense to submit to Congress a report on emerging investigational treatment options for treatment-resistant post-traumatic stress disorder in veterans, members of the Armed Forces, and members transitioning to civilian life, and for other purposes.

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-06-30
Introduced
3
Cosponsors
HR
ⓘ
Type

Sponsor

Abraham J. Hamadeh
Abraham J. Hamadeh
Republican · AZ · Representative
Votes with party: 95.9% (582 recorded votes)

Full profile: /officials/H001098

Source: Congress.gov · FEC

Cosponsors (3)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Armed Services.

2026-06-30

Source: Congress.gov

Committee Activity

Currently in

Plain-English Summary

The Department of Defense would be required to study and report to Congress on new experimental treatments for post-traumatic stress disorder (PTSD) that don't respond to standard therapies, focusing on what's available for veterans, active-duty military members, and those leaving the military. This report would help lawmakers understand what cutting-edge treatment options exist and how accessible they are to service members struggling with severe PTSD. The goal is to identify promising new approaches that could help veterans who haven't found relief through conventional treatment methods.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.